Maravai Lifesciences Holdings: Peers

The FY2025 (Dec) proxy of Maravai Lifesciences Holdings names 17 peer companies for pay. Pay versus performance data of Maravai Lifesciences Holdings for that year is not on file, so it has no rank.

Pay peer group, FY2025 (Dec) proxy

Halozyme Therapeutics
Natera
Twist Bioscience
Sotera Health
BIO-TECHNE
Veracyte
10x Genomics
Fulgent Genetics
Repligen
Cytek Biosciences
AzentaNot disclosedNot disclosed
Guardant HealthNot disclosedNot disclosed
Lantheus HoldingsNot disclosedNot disclosed
NeogenomicsNot disclosedNot disclosed
NeogenNot disclosedNot disclosed
Tandem Diabetes CareNot disclosedNot disclosed
iRythm TechnologiesNot disclosedNot disclosed
17 companies

Changes by year

FY2025 (Dec) proxy

  • RemovedBio-Rad Laboratories, Inc.pay peer groupRelative to the 2024 peer group, the Compensation Committee approved the removal of Bio-Rad Laboratories, Inc., Neurocrine Biosciences, Inc., Masimo Corporation, Globus Medical, Inc., and Insulet Corporation, each of whom, at the time of selection of the revised peer group, were much larger than us with respect to revenue and market capitalization
  • RemovedGlobus Medicalpay peer groupRelative to the 2024 peer group, the Compensation Committee approved the removal of Bio-Rad Laboratories, Inc., Neurocrine Biosciences, Inc., Masimo Corporation, Globus Medical, Inc., and Insulet Corporation, each of whom, at the time of selection of the revised peer group, were much larger than us with respect to revenue and market capitalization
  • RemovedInsuletpay peer groupRelative to the 2024 peer group, the Compensation Committee approved the removal of Bio-Rad Laboratories, Inc., Neurocrine Biosciences, Inc., Masimo Corporation, Globus Medical, Inc., and Insulet Corporation, each of whom, at the time of selection of the revised peer group, were much larger than us with respect to revenue and market capitalization
  • RemovedMasimo Corporationpay peer groupRelative to the 2024 peer group, the Compensation Committee approved the removal of Bio-Rad Laboratories, Inc., Neurocrine Biosciences, Inc., Masimo Corporation, Globus Medical, Inc., and Insulet Corporation, each of whom, at the time of selection of the revised peer group, were much larger than us with respect to revenue and market capitalization
  • RemovedNeurocrine Biosciencespay peer groupRelative to the 2024 peer group, the Compensation Committee approved the removal of Bio-Rad Laboratories, Inc., Neurocrine Biosciences, Inc., Masimo Corporation, Globus Medical, Inc., and Insulet Corporation, each of whom, at the time of selection of the revised peer group, were much larger than us with respect to revenue and market capitalization

FY2023 (Dec) proxy

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.